<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="SARSâ€�CoVâ€�2 Zhou et al. ZhouHong1FangYan2XuTaohttps://orcid.org/0000-0001-7395-04513NiWeiâ€�Jianhttps://orcid.org/0000-0002-9844-057823niweijian@ustc.edu.cnShenAiâ€�Zong2sazljl@126.comMengXiaoâ€�Minghttps://orcid.org/0000-0002-1166-561X3mengxiaoming@ahmu.edu.cn[1], Department of Pharmacy, Anhui Provincial" exact="Cancer" post="Hospital, The First Affiliated Hospital of USTC, Division of"/>
 <result pre="of Science and Technology of ChinaHefeiChina[3], Inflammation and Immune Mediated" exact="Diseases" post="Laboratory of Anhui Province, Anhui Institute of Innovative Drugs,"/>
 <result pre="China. Email: niweijian@ustc.edu.cn; sazljl@126.com Xiaoâ€�Ming Meng, Inflammation and Immune Mediated" exact="Diseases" post="Laboratory of Anhui Province, Anhui Institute of Innovative Drugs,"/>
 <result pre="applications for combating SARSâ€�CoVâ€�2. Funding Fundamental Research Funds for the" exact="Central" post="Universities 10.13039/501100012226 WK9110000018 Anhui Provincial Natural Science Foundation 10.13039/501100003995"/>
 <result pre="B and L CC50 halfâ€�cytotoxic concentration COVIDâ€�19 SARSâ€�CoVâ€�2 caused coronavirus" exact="disease" post="2019 CoVs coronaviruses DPPâ€�4 dipeptidyl peptidaseâ€�4 ECMO extracorporeal membrane"/>
 <result pre="protein 10 IRF3 IFN regulatory factor 3 MERSâ€�CoV Middle East" exact="respiratory" post="syndrome coronavirus Mpro main protease nsps nonstructural proteins PARP1"/>
 <result pre="10 IRF3 IFN regulatory factor 3 MERSâ€�CoV Middle East respiratory" exact="syndrome" post="coronavirus Mpro main protease nsps nonstructural proteins PARP1 polyâ€�ADPâ€�ribose"/>
 <result pre="protease nsps nonstructural proteins PARP1 polyâ€�ADPâ€�ribose polymerase 1 PARS pneumoniaâ€�associated" exact="respiratory" post="syndrome PLpro papainâ€�like protease RBD receptor binding domain RBM"/>
 <result pre="nsps nonstructural proteins PARP1 polyâ€�ADPâ€�ribose polymerase 1 PARS pneumoniaâ€�associated respiratory" exact="syndrome" post="PLpro papainâ€�like protease RBD receptor binding domain RBM receptor"/>
 <result pre="binding motif RBV ribavirin RdRP RNAâ€�dependent RNA polymerase SARSâ€�CoV severe" exact="acute" post="respiratory syndrome coronavirus SARSâ€�CoVâ€�2 severe acute respiratory syndrome coronavirus"/>
 <result pre="motif RBV ribavirin RdRP RNAâ€�dependent RNA polymerase SARSâ€�CoV severe acute" exact="respiratory" post="syndrome coronavirus SARSâ€�CoVâ€�2 severe acute respiratory syndrome coronavirus 2"/>
 <result pre="RBV ribavirin RdRP RNAâ€�dependent RNA polymerase SARSâ€�CoV severe acute respiratory" exact="syndrome" post="coronavirus SARSâ€�CoVâ€�2 severe acute respiratory syndrome coronavirus 2 scFv"/>
 <result pre="RNA polymerase SARSâ€�CoV severe acute respiratory syndrome coronavirus SARSâ€�CoVâ€�2 severe" exact="acute" post="respiratory syndrome coronavirus 2 scFv single chain variable fragment"/>
 <result pre="polymerase SARSâ€�CoV severe acute respiratory syndrome coronavirus SARSâ€�CoVâ€�2 severe acute" exact="respiratory" post="syndrome coronavirus 2 scFv single chain variable fragment siRNAs"/>
 <result pre="SARSâ€�CoV severe acute respiratory syndrome coronavirus SARSâ€�CoVâ€�2 severe acute respiratory" exact="syndrome" post="coronavirus 2 scFv single chain variable fragment siRNAs small"/>
 <result pre="1 INTRODUCTION In December 2019, a new coronavirus called severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARSâ€�CoVâ€�2) caused an epidemic in"/>
 <result pre="INTRODUCTION In December 2019, a new coronavirus called severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARSâ€�CoVâ€�2) caused an epidemic in Wuhan,"/>
 <result pre="In December 2019, a new coronavirus called severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARSâ€�CoVâ€�2) caused an epidemic in Wuhan, a"/>
 <result pre="the World Health Organization (WHO) declared that SARSâ€�CoVâ€�2 caused coronavirus" exact="disease" post="2019 (COVIDâ€�19), a public health emergency of international concern,"/>
 <result pre="from 26 to 32 kilobases, which makes it the largest" exact="viral" post="RNA known (Livingston, Bucher, &amp;amp; Rekito, 2020). Currently, six"/>
 <result pre="highly pathogenic CoVs. Among the highly pathogenic CoVs, both severe" exact="acute" post="respiratory syndrome coronavirus (SARSâ€�CoV, 2002, southern China) and Middle"/>
 <result pre="pathogenic CoVs. Among the highly pathogenic CoVs, both severe acute" exact="respiratory" post="syndrome coronavirus (SARSâ€�CoV, 2002, southern China) and Middle East"/>
 <result pre="CoVs. Among the highly pathogenic CoVs, both severe acute respiratory" exact="syndrome" post="coronavirus (SARSâ€�CoV, 2002, southern China) and Middle East respiratory"/>
 <result pre="respiratory syndrome coronavirus (SARSâ€�CoV, 2002, southern China) and Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV, 2012, Saudi Arabia), which mainly infect"/>
 <result pre="syndrome coronavirus (SARSâ€�CoV, 2002, southern China) and Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV, 2012, Saudi Arabia), which mainly infect the"/>
 <result pre="syndrome coronavirus (MERSâ€�CoV, 2012, Saudi Arabia), which mainly infect the" exact="lower" post="airways and cause serious fatal pneumonia, are known and"/>
 <result pre="of Sarbecovirus, which contains a positiveâ€�sense singleâ€�stranded RNA as the" exact="hereditary" post="substance and is wrapped in a nucleocapsid protein in"/>
 <result pre="in a nucleocapsid protein in the core region and a" exact="peripheral" post="envelope consisting of the spike protein, envelope protein, and"/>
 <result pre="by the nucleocapsid protein in the core area and a" exact="peripheral" post="envelope consisting of the spike (S) protein, envelope ("/>
 <result pre="SARSâ€�CoVâ€�2 is spread between individuals mainly by means of the" exact="respiratory" post="system and droplets (Phan et al., 2020). At present,"/>
 <result pre="alveolar cells, myocardial cells, renal proximal tubule cells, and oesophageal" exact="epithelial" post="cells), and the most likely reason is related to"/>
 <result pre="epithelial cells), and the most likely reason is related to" exact="infections" post="and ACE2 distribution (Yang et al., 2020; Zou et"/>
 <result pre="Epidemiological surveys have found that the clinical features of SARSâ€�CoVâ€�2" exact="infection" post="are similar to those of SARSâ€�CoV and are characterized"/>
 <result pre="patients, whereas nonâ€�respiratory clinical symptoms such as diarrhoea, sore throat," exact="muscle" post="ache, headache, and vomiting have also been reported in"/>
 <result pre="patients (Meo et al., 2020). Confirmed patients have also developed" exact="acute" post="respiratory distress syndrome, while critical illness may present with"/>
 <result pre="(Meo et al., 2020). Confirmed patients have also developed acute" exact="respiratory" post="distress syndrome, while critical illness may present with respiratory"/>
 <result pre="acute respiratory distress syndrome, while critical illness may present with" exact="respiratory" post="and lung function failure, even multiple organ dysfunction and"/>
 <result pre="respiratory and lung function failure, even multiple organ dysfunction and" exact="septic shock," post="which require extracorporeal membrane oxygenation (ECMO) and intensive care"/>
 <result pre="al., 2020). The major pathological characteristics of the lung include" exact="pulmonary" post="alveolitis and bronchiolitis with epithelial cell proliferation, desquamation, squamous"/>
 <result pre="2020). The major pathological characteristics of the lung include pulmonary" exact="alveolitis" post="and bronchiolitis with epithelial cell proliferation, desquamation, squamous metaplasia,"/>
 <result pre="major pathological characteristics of the lung include pulmonary alveolitis and" exact="bronchiolitis" post="with epithelial cell proliferation, desquamation, squamous metaplasia, and the"/>
 <result pre="characteristics of the lung include pulmonary alveolitis and bronchiolitis with" exact="epithelial" post="cell proliferation, desquamation, squamous metaplasia, and the production of"/>
 <result pre="and the production of mucus and oedema fluid. Meanwhile, massive" exact="diffuse" post="pulmonary interstitial fibrosis accompanied by excessive inflammation, a certain"/>
 <result pre="the production of mucus and oedema fluid. Meanwhile, massive diffuse" exact="pulmonary" post="interstitial fibrosis accompanied by excessive inflammation, a certain amount"/>
 <result pre="production of mucus and oedema fluid. Meanwhile, massive diffuse pulmonary" exact="interstitial fibrosis" post="accompanied by excessive inflammation, a certain amount of hyaline"/>
 <result pre="a certain amount of hyaline degeneration, and variable levels of" exact="pulmonary" post="haemorrhagic infarction have been observed at the lesion site"/>
 <result pre="et al., 2020). Moreover, several kinds of immune cells, including" exact="focal" post="monocytes, lymphocytes, plasma cells, and several multinucleate giant cells"/>
 <result pre="plasma cells, and several multinucleate giant cells along with intracytoplasmic" exact="viral" post="inclusion bodies, infiltrate into the pulmonary interstitium (Cheng et"/>
 <result pre="cells along with intracytoplasmic viral inclusion bodies, infiltrate into the" exact="pulmonary" post="interstitium (Cheng et al., 2020). In addition, immunohistochemical studies"/>
 <result pre="results for immune cells, and pathological staining also showed extensive" exact="pulmonary" post="interstitial fibrosis. Eventually, these abnormal pathological changes result in"/>
 <result pre="for immune cells, and pathological staining also showed extensive pulmonary" exact="interstitial fibrosis." post="Eventually, these abnormal pathological changes result in lung function"/>
 <result pre="confirmed cases and mortality are rapidly increasing daily, with only" exact="symptomatic" post="treatment available. This situation means that research to confirm"/>
 <result pre="clear SARSâ€�CoVâ€�2 infection, despite the immediate pressing need to identify" exact="symptomatic" post="strategies to ease suffering and prevent potential death (Morse,"/>
 <result pre="possible transmission, infection, and pathogenesis cycle of SARSâ€�CoVâ€�2. In the" exact="infection" post="phase, SARSâ€�CoVâ€�2 attaches to the cellular receptor via the"/>
 <result pre="to block SARSâ€�CoVâ€�2 infection, which can be regarded as the" exact="primary" post="factor that needs to be studied in depth. Based"/>
 <result pre="and drug R&amp;amp;D institutions to provide passive immunization against the" exact="infection" post="(Ahmed, Quadeer, &amp;amp; McKay, 2020). According to the functional"/>
 <result pre="sixâ€�helical bundle (6â€�HB), which facilitates the fusion process of the" exact="viral" post="and host cell membranes. Drawing on experience with SARSâ€�CoV,"/>
 <result pre="and valsartan, might be beneficial for those patients who experienced" exact="pneumonia" post="induced by SARSâ€�CoVâ€�2 (Sun, et al., 2020). However, unfortunately,"/>
 <result pre="cell membrane ACE2 protein, thus preventing the entry and subsequent" exact="infection" post="by SARSâ€�CoVâ€�2. This promising intervention strategy was shown to"/>
 <result pre="SARSâ€�CoVâ€�2. This promising intervention strategy was shown to significantly block" exact="viral" post="entry and replication in experiments, but additional tests are"/>
 <result pre="experiments, but additional tests are needed to identify any antiâ€�SARSâ€�CoVâ€�2" exact="infection" post="effects (Li et al., 2003). Alternatively, people could simply"/>
 <result pre="quite promising and it would be feasible to inhibit SARSâ€�CoVâ€�2" exact="infection" post="of cells, including Veroâ€�E6 cells, human capillary organoids, and"/>
 <result pre="are two critical proteases contributing to the pathogenicity of coronavirus" exact="infections" post="(Iwataâ€�Yoshikawa et al., 2019). Research has found that SARSâ€�CoVâ€�2"/>
 <result pre="been approved for safety for the treatment of pancreatic inflammatory" exact="disease" post="in Japan, which reminds us that camostat mesylate should"/>
 <result pre="nafamostat mesylate may also be a promising inhibitor of SARSâ€�CoVâ€�2" exact="infection" post="by targeting TMPRSS2 (Inoue, 2020). As these two drugs"/>
 <result pre="to the immunoglobulin family, which is closely associated with many" exact="disease" post="processes, such as tumour progression, plasmodium invasion, and virus"/>
 <result pre="many disease processes, such as tumour progression, plasmodium invasion, and" exact="virus infection" post="(Lu et al., 2018; Nguyen &amp;amp; Kamil, 2018; Zhang"/>
 <result pre="disease processes, such as tumour progression, plasmodium invasion, and virus" exact="infection" post="(Lu et al., 2018; Nguyen &amp;amp; Kamil, 2018; Zhang"/>
 <result pre="peptide (AP)â€�9 has high binding activity to effectively prevent SARSâ€�CoV" exact="infection" post="of HEK293 cells (Chen et al., 2005). Due to"/>
 <result pre="localization and binding status of CD147 and S protein during" exact="infection" post="and observed that the S protein and CD147 were"/>
 <result pre="the S protein and CD147 were present mainly in the" exact="viral" post="inclusion bodies of Vero E6 cells by immunoâ€�electron microscopy"/>
 <result pre="needed to confirm that CD147 acts as a coâ€�receptor, a" exact="secondary" post="receptor or an equally important new receptor. Additionally, whether"/>
 <result pre="Kadomatsu, 2015; Su &amp;amp; Yang, 2018). Therefore, the route of" exact="viral" post="entry involving CD147 suggests a novel potential target with"/>
 <result pre="as metuximab, metuzumab, and meplazumab) verification and exploration. 3.5 Potential" exact="viral" post="replicase targets and promising drugs In a review of"/>
 <result pre="cells to form favipiravirâ€�RTP, which is considered a substrate for" exact="viral" post="RNA polymerase, thereby binding with RdRP to inhibit its"/>
 <result pre="Nakamura, 2017). A favipiravir clinical trial (ChiCTR2000029600) for treating SARSâ€�CoVâ€�2" exact="infection" post="achieved the expected results. In the clinical trial, a"/>
 <result pre="infection achieved the expected results. In the clinical trial, a" exact="total" post="of 80 patients were divided into two groups, that"/>
 <result pre="Wang et al. found that remdesivir can effectively prevent the" exact="infection" post="of SARSâ€�CoVâ€�2 at a very low concentration with a"/>
 <result pre="is very likely to be a potential drug against SARSâ€�CoVâ€�2" exact="infection" post="(Wang, Cao et al., 2020). Furthermore, a report that"/>
 <result pre="the important roles of PLpro in the virus replication and" exact="infection" post="processes. A recent study demonstrated that PLpro in SARSâ€�CoVâ€�2"/>
 <result pre="2014). However, there were no distinct differences in the three" exact="secondary" post="structure components that formed the active sites of the"/>
 <result pre="inhibitors targeting SARSâ€�CoVâ€�2 PLpro could be as effective. The main" exact="viral" post="protease is also known as 3Câ€�like main protease (3CLpro)"/>
 <result pre="the most crucial proteases for RdRP generation, virus replication, and" exact="infection" post="(Zhou et al., 2019). Similar to the RdRP protein,"/>
 <result pre="interpretation of the crystal structure of replicases. 3.6 Targeting the" exact="viral" post="genome and promising drugs With the publication of the"/>
 <result pre="SARSâ€�CoVâ€�2 (GenBank: MN908947), one strategy could aim to target the" exact="viral" post="RNA genome itself for degradation, in addition to targeting"/>
 <result pre="for degradation, in addition to targeting the surface proteins and" exact="viral" post="replicases. Therefore, using small interfering RNAs (siRNAs), RNA aptamers"/>
 <result pre="of SARSâ€�CoV. ASOs have also been designed to detect SARSâ€�CoV" exact="infections" post="and to prevent or cure SARSâ€�CoVâ€�related disease (Lim et"/>
 <result pre="to detect SARSâ€�CoV infections and to prevent or cure SARSâ€�CoVâ€�related" exact="disease" post="(Lim et al., 2006). Before the occurrence of SARSâ€�CoVâ€�2,"/>
 <result pre="class of biological agents with potential antiviral effects. Although the" exact="viral" post="genome may be a potential target of siRNAs, RNA"/>
 <result pre="and release processes to inhibit SARSâ€�CoVâ€�2 infection, how to prevent" exact="viral" post="evasion from host immune responses and virusâ€�induced cytopathic effects"/>
 <result pre="urgent problems that need to be solved in SARSâ€�CoVâ€�2â€�induced pneumoniaâ€�associated" exact="respiratory" post="syndrome (PARS) patients. Studies from SARSâ€�CoVâ€�induced deaths and animal"/>
 <result pre="problems that need to be solved in SARSâ€�CoVâ€�2â€�induced pneumoniaâ€�associated respiratory" exact="syndrome" post="(PARS) patients. Studies from SARSâ€�CoVâ€�induced deaths and animal models"/>
 <result pre="cytokine storm results in a strong immunopathological response and lethal" exact="disease" post="(Hui &amp;amp; Zumla, 2019; Rockx et al., 2009; Smits"/>
 <result pre="&amp;amp; He, 2020), and it is closely associated with multiple" exact="infectious" post="and nonâ€�infectious conditions and diseases including graftâ€�versusâ€�host disease, autoimmune"/>
 <result pre="multiple infectious and nonâ€�infectious conditions and diseases including graftâ€�versusâ€�host disease," exact="autoimmune disease," post="severe virus infection, multiple organ dysfunction syndrome, and chimeric"/>
 <result pre="nonâ€�infectious conditions and diseases including graftâ€�versusâ€�host disease, autoimmune disease, severe" exact="virus infection," post="multiple organ dysfunction syndrome, and chimeric antigen receptor (CAR)â€�T"/>
 <result pre="to produce GMâ€�CSF. The cytokine condition contributes to CD14+ CD16+" exact="monocyte" post="recruitment and ILâ€�6 secretion, which further aggravate the inflammatory"/>
 <result pre="ILâ€�6 secretion, which further aggravate the inflammatory response after SARSâ€�CoVâ€�2" exact="infection" post="(Li et al., 2020; Zhou et al., 2020). Recently,"/>
 <result pre="al., 2020). These clinical indicators reveal the presence of severe" exact="pulmonary" post="inflammation and the production of inflammatory cytokine storms during"/>
 <result pre="the production of inflammatory cytokine storms during SARSâ€�CoVâ€�2 infection. Therefore," exact="symptomatic" post="treatments, especially strategies to eliminate inflammation and inflammatory cytokine"/>
 <result pre="use and shows proven safety and effectiveness in therapy for" exact="rheumatoid arthritis" post="(Safyâ€�Khan et al., 2020; Verhoeven et al., 2019). To"/>
 <result pre="and shows proven safety and effectiveness in therapy for rheumatoid" exact="arthritis" post="(Safyâ€�Khan et al., 2020; Verhoeven et al., 2019). To"/>
 <result pre="by varying degrees of improvement in the oxygenation index of" exact="respiratory" post="function. After 2 weeks of careful treatment by the"/>
 <result pre="significantly suppressed CpGâ€�induced ILâ€�6 production by 50% and 73% in" exact="peripheral" post="blood mononuclear cells at 1 and 3 Î¼M concentrations"/>
 <result pre="convalescent patient sera Vaccination is the best strategy to prevent" exact="infections" post="and diseases by exposure to specific pathogens, especially in"/>
 <result pre="vaccine (Zhang, 2020a). On January 23, 2020, the Coalition for" exact="Epidemic" post="Preparedness Innovations (CEPI) declared that they would fund three"/>
 <result pre="mRNAâ€�1273, entered Phase I human study (NCT04283461), which represented a" exact="total" post="of 63 days from sequence selection to first human"/>
 <result pre="same day, another exciting development of a subunit vaccine (adenovirus" exact="Type 5" post="vector) against SARSâ€�CoVâ€�2 was created by experts of the"/>
 <result pre="which can be obtained from patients who have recovered from" exact="virus infection." post="This passive strategy has been shown to be effective"/>
 <result pre="been shown to be effective in the treatment of other" exact="viral" post="diseases (Mire et al., 2016). Based on experience, patients"/>
 <result pre="(Mire et al., 2016). Based on experience, patients with resolved" exact="infection" post="will develop viral antibodies at a high titre in"/>
 <result pre="2016). Based on experience, patients with resolved infection will develop" exact="viral" post="antibodies at a high titre in response to different"/>
 <result pre="be transfused into other infected patients to help them overcome" exact="viral" post="infections. As plasma donation is a mature technology, and"/>
 <result pre="potential of molecules derived from traditional Chinese medicine to treat" exact="infections" post="caused by SARSâ€�CoVâ€�2 As SARSâ€�CoVâ€�2 infection has become more"/>
 <result pre="Chinese medicine to treat infections caused by SARSâ€�CoVâ€�2 As SARSâ€�CoVâ€�2" exact="infection" post="has become more rampant worldwide, there is an equally"/>
 <result pre="important role in this epidemic situation. According to statistics, a" exact="total" post="of 60,107 patients infected with SARSâ€�CoVâ€�2 in China were"/>
 <result pre="and Mori cortex) of them are classically catalogued as treating" exact="viral" post="respiratory infections. In addition, network pharmacology analysis predicted that"/>
 <result pre="Mori cortex) of them are classically catalogued as treating viral" exact="respiratory" post="infections. In addition, network pharmacology analysis predicted that these"/>
 <result pre="predicted that these 26 TCMs have general roles, including regulating" exact="viral infection," post="immune/inflammation reactions, and the hypoxia response in vivo (Zhang,"/>
 <result pre="general roles, including regulating viral infection, immune/inflammation reactions, and the" exact="hypoxia" post="response in vivo (Zhang, Wu, et al., 2020). The"/>
 <result pre="in combating SARSâ€�CoVâ€�2. Although there have been some clues regarding" exact="viral" post="pathogenesis and potential targets, there are no verified antiviral"/>
 <result pre="block the outbreak of SARSâ€�CoVâ€�2 worldwide, we hope that the" exact="infection" post="and transmission of this virus will recede in a"/>
 <result pre="Foundation (No. 1708085QH207), and the Fundamental Research Funds for the" exact="Central" post="Universities (No. WK9110000018). References REFERENCES Adedeji, A. O., Singh,"/>
 <result pre="L., Enjuanes, L., Weiss, S., &amp;amp; Sarafianos, S. G. (2012)." exact="Severe" post="acute respiratory syndrome coronavirus replication inhibitor that interferes with"/>
 <result pre="Enjuanes, L., Weiss, S., &amp;amp; Sarafianos, S. G. (2012). Severe" exact="acute" post="respiratory syndrome coronavirus replication inhibitor that interferes with the"/>
 <result pre="L., Weiss, S., &amp;amp; Sarafianos, S. G. (2012). Severe acute" exact="respiratory" post="syndrome coronavirus replication inhibitor that interferes with the nucleic"/>
 <result pre="Weiss, S., &amp;amp; Sarafianos, S. G. (2012). Severe acute respiratory" exact="syndrome" post="coronavirus replication inhibitor that interferes with the nucleic acid"/>
 <result pre="inhibitor that interferes with the nucleic acid unwinding of the" exact="viral" post="helicase. Antimicrobial Agents and Chemotherapy, 56(9), 4718â€&quot;4728. 10.1128/AAC.00957-1222733076 Adedeji,"/>
 <result pre="(2014). Evaluation of SSYA10â€�001 as a replication inhibitor of severe" exact="acute" post="respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome"/>
 <result pre="Evaluation of SSYA10â€�001 as a replication inhibitor of severe acute" exact="respiratory" post="syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses."/>
 <result pre="of severe acute respiratory syndrome, mouse hepatitis, and Middle East" exact="respiratory" post="syndrome coronaviruses. Antimicrobial Agents and Chemotherapy, 58(8), 4894â€&quot;4898. 10.1128/AAC.02994-1424841268"/>
 <result pre="severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory" exact="syndrome" post="coronaviruses. Antimicrobial Agents and Chemotherapy, 58(8), 4894â€&quot;4898. 10.1128/AAC.02994-1424841268 Ahmed,"/>
 <result pre="Vaccine Targets for the COVIDâ€�19 Coronavirus (SARSâ€�CoVâ€�2) Based on SARSâ€�CoV" exact="Immunological" post="Studies. Viruses, 12(3), 1â€&quot;15. 10.3390/v12030254 Ahn, D. G., Jeon,"/>
 <result pre="Kumar, B. (2018). Advancements in Nucleic Acid Based Therapeutics against" exact="Respiratory" post="Viral Infections. Journal of Clinical Medicine, 8(1), 1â€&quot;24. 10.3390/jcm8010006"/>
 <result pre="B. (2018). Advancements in Nucleic Acid Based Therapeutics against Respiratory" exact="Viral" post="Infections. Journal of Clinical Medicine, 8(1), 1â€&quot;24. 10.3390/jcm8010006 Baezâ€�Santos,"/>
 <result pre="Zangrillo, A. (2020). Minimise nosocomial spread of 2019â€�nCoV when treating" exact="acute" post="respiratory failure. Lancet, 395(10225), 68510.1016/S0140-6736(20)30359-7 Cao, B., Wang, Y.,"/>
 <result pre="A. (2020). Minimise nosocomial spread of 2019â€�nCoV when treating acute" exact="respiratory" post="failure. Lancet, 395(10225), 68510.1016/S0140-6736(20)30359-7 Cao, B., Wang, Y., Wen,"/>
 <result pre="the 2019 novel humanâ€�pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting Wuhan. Emerg Microbes Infect, 9(1), 221â€&quot;236. 10.1080/22221751.2020.171990231987001"/>
 <result pre="2019 novel humanâ€�pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting Wuhan. Emerg Microbes Infect, 9(1), 221â€&quot;236. 10.1080/22221751.2020.171990231987001"/>
 <result pre="in the research of cytokine storm mechanism induced by Corona" exact="Virus Disease" post="2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za"/>
 <result pre="the research of cytokine storm mechanism induced by Corona Virus" exact="Disease" post="2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: A descriptive study. Lancet, 395(10223), 507â€&quot;513."/>
 <result pre="Function of HAb18G/CD147 in invasion of host cells by severe" exact="acute" post="respiratory syndrome coronavirus. The Journal of Infectious Diseases, 191(5),"/>
 <result pre="of HAb18G/CD147 in invasion of host cells by severe acute" exact="respiratory" post="syndrome coronavirus. The Journal of Infectious Diseases, 191(5), 755â€&quot;760."/>
 <result pre="HAb18G/CD147 in invasion of host cells by severe acute respiratory" exact="syndrome" post="coronavirus. The Journal of Infectious Diseases, 191(5), 755â€&quot;760. 10.1086/42781115688292"/>
 <result pre="cells by severe acute respiratory syndrome coronavirus. The Journal of" exact="Infectious" post="Diseases, 191(5), 755â€&quot;760. 10.1086/42781115688292 Cheng, J. L., Huang, C.,"/>
 <result pre="Y., &amp;amp; Li, J. (2020). Epidemiological characteristics of novel coronavirus" exact="pneumonia" post="in Henan. Zhonghua Jie He He Hu Xi Za"/>
 <result pre="mycophenolic acid synergistically inhibit the papainâ€�like protease of Middle East" exact="respiratory" post="syndrome coronavirus. Antiviral Research, 115, 9â€&quot;16. 10.1016/j.antiviral.2014.12.01125542975 Clasman, J."/>
 <result pre="acid synergistically inhibit the papainâ€�like protease of Middle East respiratory" exact="syndrome" post="coronavirus. Antiviral Research, 115, 9â€&quot;16. 10.1016/j.antiviral.2014.12.01125542975 Clasman, J. R.,"/>
 <result pre="Spinelli, S., Bebeacua, C., Blangy, S., â€¦ Cambillau, C. (2013)." exact="Viral" post="infection modulation and neutralization by camelid nanobodies. Proceedings of"/>
 <result pre="S., Bebeacua, C., Blangy, S., â€¦ Cambillau, C. (2013). Viral" exact="infection" post="modulation and neutralization by camelid nanobodies. Proceedings of the"/>
 <result pre="S., &amp;amp; Gao, J. (2020). Discovering drugs to treat coronavirus" exact="disease" post="2019 (COVIDâ€�19). Drug Discov Ther, 14(1), 58â€&quot;60. 10.5582/ddt.2020.0101232147628 Fung,"/>
 <result pre="Nakamura, T. (2017). Favipiravir (Tâ€�705), a broad spectrum inhibitor of" exact="viral" post="RNA polymerase. Proceedings of the Japan Academy. Series B,"/>
 <result pre="A., &amp;amp; Sadelain, M. (2018). CAR T cellâ€�induced cytokine release" exact="syndrome" post="is mediated by macrophages and abated by ILâ€�1 blockade."/>
 <result pre="clinical diagnosis and treatment of a case infected with coronavirus" exact="disease" post="2019. Journal of Medical Virology, 92(5), 461â€&quot;463. 10.1002/jmv.2571132073161 Harding,"/>
 <result pre="Lancet, 395(10223), 497â€&quot;506. 10.1016/S0140-6736(20)30183-531986264 Hui, D., &amp;amp; Zumla, A. (2019)." exact="Severe" post="acute respiratory syndrome: Historical, epidemiologic, and clinical features. Infectious"/>
 <result pre="395(10223), 497â€&quot;506. 10.1016/S0140-6736(20)30183-531986264 Hui, D., &amp;amp; Zumla, A. (2019). Severe" exact="acute" post="respiratory syndrome: Historical, epidemiologic, and clinical features. Infectious Disease"/>
 <result pre="497â€&quot;506. 10.1016/S0140-6736(20)30183-531986264 Hui, D., &amp;amp; Zumla, A. (2019). Severe acute" exact="respiratory" post="syndrome: Historical, epidemiologic, and clinical features. Infectious Disease Clinics"/>
 <result pre="(2019). Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features." exact="Infectious" post="Disease Clinics of North America, 33(4), 869â€&quot;889. 10.1016/j.idc.2019.07.00131668196 Hukowskaâ€�Szematowicz,"/>
 <result pre="Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features. Infectious" exact="Disease" post="Clinics of North America, 33(4), 869â€&quot;889. 10.1016/j.idc.2019.07.00131668196 Hukowskaâ€�Szematowicz, B."/>
 <result pre="111â€&quot;122. 10.18388/abp.2020_516132129974 Inoue, J (2020). Identification of an existing Japanese" exact="pancreatitis" post="drug, Nafamostat, which is expected to prevent the transmission"/>
 <result pre="which is expected to prevent the transmission of new coronavirus" exact="Infection" post="(COVIDâ€�19). Retrieved from https://www.uâ€�tokyo.ac.jp/focus/en/articles/z0508_00083.html. Iwataâ€�Yoshikawa, N., Okamura, T., Shimizu,"/>
 <result pre="TKMâ€�100802 and convalescent plasma in 2 patients with Ebola virus" exact="disease" post="in the United States. Clinical Infectious Diseases, 61(4), 496â€&quot;502."/>
 <result pre="patients with Ebola virus disease in the United States. Clinical" exact="Infectious" post="Diseases, 61(4), 496â€&quot;502. 10.1093/cid/civ33425904375 Kruse, R. L. (2020). Therapeutic"/>
 <result pre="T., Li, Z., Zhou, P., â€¦ Wu, J. (2020). Coronavirus" exact="infections" post="and immune responses. Journal of Medical Virology, 92(4), 424â€&quot;432."/>
 <result pre="W., Xia, Y., â€¦ Shen, F. (2020). Adjuvant (131)Iâ€�metuximab for" exact="hepatocellular carcinoma" post="after liver resection: A randomised, controlled, multicentre, openâ€�label, phase"/>
 <result pre="Xia, Y., â€¦ Shen, F. (2020). Adjuvant (131)Iâ€�metuximab for hepatocellular" exact="carcinoma" post="after liver resection: A randomised, controlled, multicentre, openâ€�label, phase"/>
 <result pre="and vaccines for COVIDâ€�19 and related human coronavirus diseases. ACS" exact="Central" post="SCI, 6(3), 315â€&quot;331. 10.1021/acscentsci.0c00272 Liu, J., &amp;amp; Guo, B."/>
 <result pre="of coronavirus spike proteins and host ACE2 receptors predict potential" exact="intermediate" post="hosts of SARSâ€�CoVâ€�2. Journal of Medical Virology, 92(6), 595â€&quot;601."/>
 <result pre="10.1002/jmv.2572632100877 Livingston, E., Bucher, K., &amp;amp; Rekito, A. (2020). Coronavirus" exact="Disease" post="2019 and Influenza 2019â€�2020. JAMA, 323(12), 1122â€&quot;1122. 10.1001/jama.2020.263332207769 Lu,"/>
 <result pre="induces hepatocyte polarity loss by Eâ€�cadherin ubiquitination and degradation in" exact="hepatocellular carcinoma" post="progress. Hepatology, 68(1), 317â€&quot;332. 10.1002/hep.2979829356040 Lu, R., Zhao, X.,"/>
 <result pre="hepatocyte polarity loss by Eâ€�cadherin ubiquitination and degradation in hepatocellular" exact="carcinoma" post="progress. Hepatology, 68(1), 317â€&quot;332. 10.1002/hep.2979829356040 Lu, R., Zhao, X.,"/>
 <result pre="L (2020). Clinical pathology of critical patient with novel coronavirus" exact="pneumonia" post="(COVIDâ€�19). Preprints. 10.13140/RG.2.2.22934.29762 Maâ€�Lauer, Y., Carbajoâ€�Lozoya, J., Hein, M."/>
 <result pre="Passive immunotherapy: Assessment of convalescent serum against Ebola virus Makona" exact="infection" post="in nonhuman primates. The Journal of Infectious Diseases, 214(suppl"/>
 <result pre="Ebola virus Makona infection in nonhuman primates. The Journal of" exact="Infectious" post="Diseases, 214(suppl 3), S367â€&quot;S374. 10.1093/infdis/jiw33327571900 Mizutani, T., Fukushi, S.,"/>
 <result pre="â€¦ Morikawa, S. (2006). Inhibition of cell proliferation by SARSâ€�CoV" exact="infection" post="in Vero E6 cells. FEMS Immunology and Medical Microbiology,"/>
 <result pre="the past: Possible urgent prevention and treatment options for severe" exact="acute" post="respiratory infections caused by 2019â€�nCoV. Chembiochem, 21(5), 730â€&quot;738. 10.1002/cbic.20200004732022370"/>
 <result pre="past: Possible urgent prevention and treatment options for severe acute" exact="respiratory" post="infections caused by 2019â€�nCoV. Chembiochem, 21(5), 730â€&quot;738. 10.1002/cbic.20200004732022370 Nguyen,"/>
 <result pre="Possible urgent prevention and treatment options for severe acute respiratory" exact="infections" post="caused by 2019â€�nCoV. Chembiochem, 21(5), 730â€&quot;738. 10.1002/cbic.20200004732022370 Nguyen, C."/>
 <result pre="coronavirus: Humanâ€�toâ€�human transmission, travelâ€�related cases, and vaccine readiness. Journal of" exact="Infection" post="in Developing Countries, 14(1), 3â€&quot;17. 10.3855/jidc.1242532088679 Ratia, K., Kilianski,"/>
 <result pre="Baezâ€�Santos, Y. M., Baker, S. C., &amp;amp; Mesecar, A. (2014)." exact="Structural" post="basis for the ubiquitinâ€�linkage specificity and deISGylating activity of"/>
 <result pre="Frieman, M., â€¦ Katze, M. G. (2009). Early upregulation of" exact="acute" post="respiratory distress syndromeâ€�associated cytokines promotes lethal disease in an"/>
 <result pre="M., â€¦ Katze, M. G. (2009). Early upregulation of acute" exact="respiratory" post="distress syndromeâ€�associated cytokines promotes lethal disease in an agedâ€�mouse"/>
 <result pre="Early upregulation of acute respiratory distress syndromeâ€�associated cytokines promotes lethal" exact="disease" post="in an agedâ€�mouse model of severe acute respiratory syndrome"/>
 <result pre="cytokines promotes lethal disease in an agedâ€�mouse model of severe" exact="acute" post="respiratory syndrome coronavirus infection. Journal of Virology, 83(14), 7062â€&quot;7074."/>
 <result pre="promotes lethal disease in an agedâ€�mouse model of severe acute" exact="respiratory" post="syndrome coronavirus infection. Journal of Virology, 83(14), 7062â€&quot;7074. 10.1128/JVI.00127-0919420084"/>
 <result pre="lethal disease in an agedâ€�mouse model of severe acute respiratory" exact="syndrome" post="coronavirus infection. Journal of Virology, 83(14), 7062â€&quot;7074. 10.1128/JVI.00127-0919420084 Safyâ€�Khan,"/>
 <result pre="outcomes of also enrolling patients on ongoing glucocorticoid therapy in" exact="rheumatoid arthritis" post="clinical trials of tocilizumab or adalimumab or methotrexate monotherapy."/>
 <result pre="of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid" exact="arthritis" post="clinical trials of tocilizumab or adalimumab or methotrexate monotherapy."/>
 <result pre="S protein induces a strong antigenâ€�specific IgG response against severe" exact="acute" post="respiratory syndromeâ€�related coronavirus infection, but fails to induce protective"/>
 <result pre="protein induces a strong antigenâ€�specific IgG response against severe acute" exact="respiratory" post="syndromeâ€�related coronavirus infection, but fails to induce protective antibodies"/>
 <result pre="coronavirus infection, but fails to induce protective antibodies and limit" exact="eosinophilic" post="infiltration in lungs. Microbiology and Immunology, 64(1), 33â€&quot;51. 10.1111/1348-0421.1275431692019"/>
 <result pre="Sanguinis, 115(2), 174â€&quot;181. 10.1111/vox.1286131845332 Vanessa, M. (2020). Inhibition of SARSâ€�CoVâ€�2" exact="infections" post="in engineered human tissues using clinicalâ€�grade soluble human ACE2."/>
 <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusâ€�infected" exact="pneumonia" post="in Wuhan, China. JAMA, 323(11), 1061â€&quot;1069. 10.1001/jama.2020.1585 Wang, K.,"/>
 <result pre="Li, Y. (2019). Dual effects of an antiâ€�CD147 antibody for" exact="esophageal cancer" post="therapy. Cancer Biology &amp;amp; Therapy, 20(12), 1443â€&quot;1452. 10.1080/15384047.2019.164705231411555 Wrapp,"/>
 <result pre="Y. (2019). Dual effects of an antiâ€�CD147 antibody for esophageal" exact="cancer" post="therapy. Cancer Biology &amp;amp; Therapy, 20(12), 1443â€&quot;1452. 10.1080/15384047.2019.164705231411555 Wrapp,"/>
 <result pre="Dual effects of an antiâ€�CD147 antibody for esophageal cancer therapy." exact="Cancer" post="Biology &amp;amp; Therapy, 20(12), 1443â€&quot;1452. 10.1080/15384047.2019.164705231411555 Wrapp, D., Wang,"/>
 <result pre="J. (2009). Glycogen synthase kinaseâ€�3 regulates the phosphorylation of severe" exact="acute" post="respiratory syndrome coronavirus nucleocapsid protein and viral replication. The"/>
 <result pre="(2009). Glycogen synthase kinaseâ€�3 regulates the phosphorylation of severe acute" exact="respiratory" post="syndrome coronavirus nucleocapsid protein and viral replication. The Journal"/>
 <result pre="Glycogen synthase kinaseâ€�3 regulates the phosphorylation of severe acute respiratory" exact="syndrome" post="coronavirus nucleocapsid protein and viral replication. The Journal of"/>
 <result pre="phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and" exact="viral" post="replication. The Journal of Biological Chemistry, 284(8), 5229â€&quot;5239. 10.1074/jbc.M80574720019106108"/>
 <result pre="S., â€¦ Wong, C. H. (2004). Small molecules targeting severe" exact="acute" post="respiratory syndrome human coronavirus. Proceedings of the National Academy"/>
 <result pre="â€¦ Wong, C. H. (2004). Small molecules targeting severe acute" exact="respiratory" post="syndrome human coronavirus. Proceedings of the National Academy of"/>
 <result pre="Wong, C. H. (2004). Small molecules targeting severe acute respiratory" exact="syndrome" post="human coronavirus. Proceedings of the National Academy of Sciences"/>
 <result pre="S., â€¦ Lu, Lu (2020). Inhibition of SARSâ€�CoVâ€�2 (previously 2019â€�nCoV)" exact="infection" post="by a highly potent panâ€�coronavirus fusion inhibitor targeting its"/>
 <result pre="Li, Y., Xia, L., Guo, Y., &amp;amp; Zhou, Q. (2020)." exact="Structural" post="basis for the recognition of the SARSâ€�CoVâ€�2 by fullâ€�length"/>
 <result pre="Clinical course and outcomes of critically ill patients with SARSâ€�CoVâ€�2" exact="pneumonia" post="in Wuhan, China: A singleâ€�centered, retrospective, observational study. The"/>
 <result pre="in Wuhan, China: A singleâ€�centered, retrospective, observational study. The Lancet" exact="Respiratory" post="Medicine, 8, 475â€&quot;481. 10.1016/S2213-2600(20)30079-532105632 Yap, Y., Zhang, X., Andonov,"/>
 <result pre="Yap, Y., Zhang, X., Andonov, A., &amp;amp; He, R. (2005)." exact="Structural" post="analysis of inhibition mechanisms of aurintricarboxylic acid on SARSâ€�CoV"/>
 <result pre="Y. (2020). Controversial treatments: An updated understanding of the coronavirus" exact="disease" post="2019. Journal of Medical Virology, 1â€&quot;22. 10.1002/jmv.2578831502247 Zhang, D."/>
 <result pre="â€¦ Tan, W. (2020). A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. The New England Journal of Medicine,"/>
 <result pre="proteinases and proteolytic processing in the Nidovirales. The Journal of" exact="General" post="Virology, 81(Pt 4), 853â€&quot;879. 10.1099/0022-1317-81-4-85310725411 Zou, X., Chen, K.,"/>
</results>
